FDA Recommends Limits to High-Dose Zocor

The U.S. Food and Drug Administration has recommended limiting high doses of a widely prescribed cholesterol-lowering drug called simvastatin -- commonly known as Zocor -- after reviewing the results of a clinical trial that found a higher risk of muscle damage compared to patients taking lower doses of the statin. The use of the 80-mg dose of Zocor, the highest approved dose of the drug, can harm muscles and potentially cause deadly kidney damage, the U.S. Food and Drug Administration warned...Full Story
Commenting on this article is closed.